Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, Utah.
Division of Maternal-Fetal Medicine, Women and Newborns Clinical Program, Intermountain Healthcare, Salt Lake City, Utah.
Am J Perinatol. 2022 Apr;39(6):567-576. doi: 10.1055/s-0041-1740237. Epub 2021 Dec 2.
To estimate the actual excess costs of care for delivery admissions complicated by severe maternal morbidity (SMM) compared with uncomplicated deliveries.
This is a retrospective cohort study of all deliveries between October 2015 and September 2018 at a single tertiary academic center. Pregnant individuals ≥ 20 weeks' gestation who delivered during a hospital admission (i.e., a "delivery admission") were included. The primary exposure was SMM, as defined by Centers for Disease Control and Prevention (CDC) criteria, CDC criteria excluding blood transfusion, or by validated hospital-defined criteria (intensive care unit admission or ≥ 4 units of blood products). Potential SMM events identified via administrative and blood bank data were reviewed to confirm SMM events had occurred. Primary outcome was total actual costs of delivery admission derived from time-based accounting and acquisition costs in the institutional Value Driven Outcomes database. Cost of delivery admissions with SMM events was compared with the cost of uncomplicated delivery using adjusted generalized linear models, with separate models for each of the SMM definitions. Relative cost differences are reported due to data restrictions.
Of 12,367 eligible individuals, 12,361 had complete cost data. Two hundred and eighty individuals (2.3%) had confirmed SMM events meeting CDC criteria. CDC criteria excluding transfusion alone occurred in 1.0% ( = 121) and hospital-defined SMM in 0.6% ( = 76). In adjusted models, SMM events by CDC criteria were associated with a relative cost increase of 2.45 times (95% confidence interval [CI]: 2.29-2.61) the cost of an uncomplicated delivery. SMM by CDC criteria excluding transfusion alone was associated with a relative increase of 3.26 (95% CI: 2.95-3.60) and hospital-defined SMM with a 4.19-fold (95% CI: 3.64-4.83) increase. Each additional CDC subcategory of SMM diagnoses conferred a relative cost increase of 1.60 (95% CI: 1.43-1.79).
SMM is associated with between 2.5- and 4-fold higher cost than uncomplicated deliveries.
· Severe maternal morbidity as defined by CDC criteria confers a 2.5-fold increase in delivery hospitalization costs.. · Intensive care unit admission or ≥ 4 units of blood products confer a fourfold increase in cost.. · Costs of maternal morbidity may motivate SMM review..
估计与无并发症分娩相比,严重产妇发病率(SMM)导致的分娩入院的实际额外护理成本。
这是一项对 2015 年 10 月至 2018 年 9 月在一家三级学术中心进行的所有分娩的回顾性队列研究。纳入妊娠 20 周以上并在住院期间分娩的个体(即“分娩入院”)。主要暴露因素是 SMM,由疾病预防控制中心(CDC)标准定义,不包括输血的 CDC 标准,或由经过验证的医院定义的标准(重症监护病房入院或≥4 单位的血液制品)。通过行政和血库数据识别的潜在 SMM 事件经过审查以确认 SMM 事件已发生。主要结局是从机构价值驱动结果数据库中的基于时间的核算和获取成本中得出的分娩入院的实际总成本。使用调整后的广义线性模型比较有 SMM 事件的分娩入院成本与无并发症分娩成本,每个 SMM 定义都有一个单独的模型。由于数据限制,报告了相对成本差异。
在 12367 名符合条件的个体中,有 12361 名个体具有完整的成本数据。280 名个体(2.3%)有经确认的符合 CDC 标准的 SMM 事件。单独使用输血的 CDC 标准占 1.0%( = 121),医院定义的 SMM 占 0.6%( = 76)。在调整后的模型中,符合 CDC 标准的 SMM 事件与无并发症分娩成本的相对增加 2.45 倍(95%置信区间[CI]:2.29-2.61)。仅排除输血的单独使用的 CDC 标准相关 SMM 与相对增加 3.26(95% CI:2.95-3.60)相关,而医院定义的 SMM 与增加 4.19 倍(95% CI:3.64-4.83)相关。每个额外的 CDC SMM 诊断亚类与相对成本增加 1.60(95% CI:1.43-1.79)相关。
SMM 与无并发症分娩相比,成本增加 2.5-4 倍。
·CDC 标准定义的严重产妇发病率导致分娩住院费用增加 2.5 倍。·重症监护病房入院或≥4 单位血液制品的费用增加 4 倍。·产妇发病率的成本可能会促使对 SMM 进行审查。